|
Therapeutic Protein Nanoparticles for the Treatment of Inflammatory Bowel Diseases
Application
Therapeutic nanoparticle of the AvrA protein for the treatment of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.
Key Benefits
AvrA protein, at 33 kilodaltons, is approximately one-fifth the molecular weight of current antibody-based biologics.
Use of uniform protein nanoparticles improves...
Published: 4/23/2024
Contributor(s): Andrew Neish, Julie Champion
|